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Abstract
Liver sinusoidal endothelial cells (LSECs) are specialized scavenger cells that mediate high-capacity clearance of soluble
waste macromolecules and colloid material, including blood-borne adenovirus. To explore if LSECs function as a sink for
other viruses in blood, we studied the fate of virus-like particles (VLPs) of two ubiquitous human DNA viruses, BK and JC
polyomavirus, in mice. Like complete virions, VLPs specifically bind to receptors and enter cells, but unlike complete virions,
they cannot replicate. 125I-labeled VLPs were used to assess blood decay, organ-, and hepatocellular distribution of ligand,
and non-labeled VLPs to examine cellular uptake by immunohisto- and -cytochemistry. BK- and JC-VLPs rapidly distributed
to liver, with lesser uptake in kidney and spleen. Liver uptake was predominantly in LSECs. Blood half-life (,1 min), and
tissue distribution of JC-VLPs and two JC-VLP-mutants (L55F and S269F) that lack sialic acid binding affinity, were similar,
indicating involvement of non-sialic acid receptors in cellular uptake. Liver uptake was not mediated by scavenger
receptors. In spleen, the VLPs localized to the red pulp marginal zone reticuloendothelium, and in kidney to the endothelial
lining of vasa recta segments, and the transitional epithelium of renal pelvis. Most VLP-positive vessels in renal medulla did
not express PV-1/Meca 32, suggesting location to the non-fenestrated part of vasa recta. The endothelial cells of these
vessels also efficiently endocytosed a scavenger receptor ligand, formaldehyde-denatured albumin, suggesting high
endocytic activity compared to other renal endothelia. We conclude that LSECs very effectively cleared a large fraction of
blood-borne BK- and JC-VLPs, indicating a central role of these cells in early removal of polyomavirus from the circulation. In
addition, we report the novel finding that a subpopulation of endothelial cells in kidney, the main organ of polyomavirus
persistence, showed selective and rapid uptake of VLPs, suggesting a role in viremic organ tropism.
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Introduction
The mucosal surfaces of the respiratory, oral-pharyngeal and
gastrointestinal tracts are constantly exposed to a multitude of
different viruses, only some of which eventually cause infection
and disease [1]. Similarly to bacteria, viruses are likely to leak from
the gut to the portal vein, and many of these viruses end up in the
liver [2–8]. Some picornaviruses such as hepatitis A virus initially
replicate in the intestinal mucosal surface and cause acute hepatitis
when reaching the liver. Other viruses such as cytomegalovirus,
Epstein-Barr virus, adenovirus, parvovirus B19, and polyomavirus
cause only limited liver damage, if at all.
The liver has a critical role in pathogen detection and host
defense, and contains the single largest number of macrophages,
the highest concentration of natural killer cells and natural killer T
cells, and the largest reticuloendothelial network in the body [9].
Of the various liver cells involved in host defense, liver sinusoidal
endothelial cells (LSECs), which line the numerous sinusoids of
this organ, are the least known. However, studies over the last
three decades have revealed that these cells are highly active
scavenger cells, removing large amounts of soluble waste
macromolecules and nanoparticulate material from blood each
day [10]. Thus, LSECS clearly play an important role as sentinel
cells of the immune system due to: 1) their location exposing them
to 25–30% of cardiac output; 2) their expression of several
molecules involved in innate immunity such as various scavenger
receptors [11–13]), the mannose receptor [14,15], toll-like
receptors 2–4, 7 and 9 [16–19], and 3) their capacity to produce
cytokines and other molecules to alert their environment [16,19].
Furthermore, LSECs express Fc gamma-receptor IIb2 [20,21],
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which mediates endocytosis of soluble immune complexes, and
other receptors involved in virus uptake such as L-SIGN [22] and
LSECtin [23]. Ligands eliminated from blood mainly by LSECs,
and to a lesser by Kupffer cells (resident liver macrophages),
include connective tissue turnover products, lysosomal enzymes
[13,15,24–26]), modified plasma proteins and lipoproteins [27–
30], soluble IgG immune complexes [31], yeast mannan [32], and
adenovirus/adenoviral vectors [7,33]. Differently to macrophages,
LSECs operate essentially via clathrin-mediated endocytosis, and
not by phagocytosis, and the cells are equipped with an endocytic
machinery capable of super-efficient uptake and degradation of
the internalized ligands [10,34]. We have previously shown that
this high scavenging activity of LSECs is conserved among all
land-based vertebrates (amphibians, reptiles, birds, mammals)
suggesting that this is a general mechanism for how soluble
macromolecular waste material, and small colloidal particles, such
as viruses, are cleared from blood [10,35].
Cellular uptake of virus has traditionally been studied in the
context of productive infection with disease-forming virus in
permissive cells. Apart from the recently reported central role of
LSECs in clearing blood-borne adenovirus and adenoviral vectors
[7,33], little is actually known about the role of LSECs in the
uptake of virus. To explore the hypothesis that these cells act as
general virus scavengers, we have studied the circulatory fate of
virus-like particles (VLPs) of two non-enveloped, human DNA
viruses; polyomavirus BK and JC (BKV and JCV), in mice. These
viruses are approximately 40–45 nm in diameter, and are taken up
in their permissive host cells via caveolin-mediated and clathrin-
mediated endocytosis, respectively [36]. The VLPs represent a
well-established model for endocytosis studies [37,38]. These
particles are empty virus capsids consisting of 72 capsomers of
polyoma viral protein 1 (VP1), which mediate the virus binding to
sialic acid receptors during infection of susceptible cells [39].
BKV and JCV infect most people early in life and establish
lifelong persistent infections in the renourinary tract with
asymptomatic episodes of viral reactivation and shedding in urine.
While reactivation of BKV may result in severe diseases in the
kidney graft and bladder of kidney- and hematopoietic stem cell
transplant patients [40], JCV may lead to severe demyelinating
brain disease, progressive multifocal leukoencephalopathy (PML)
in immunocompromised individuals, and in patients treated with
novel immunomodulatory or depleting therapies for autoimmune
diseases [41]. Following respiratory or gastrointestinal transmis-
sion, BKV and JCV colonize the renourinary tract as the major
site of persistence. To reach the renourinary tract, a viremic phase
has been postulated, but the fate of BKV and JCV when they first
appear in the circulation is currently unknown. Like most
polyomavirus, BKV and JCV replication is highly specific to the
human host, which hampered studies of replicative disease in
animal models. However, the alpha(2,3)-linked and alpha(2,6)-
linked sialic acid receptors used by BKV and JCV, respectively,
are widespread in vertebrates, including mice. This encouraged us
to study the fate of BK- and JC-VLPs in the blood and their
cellular site of uptake in a mouse model similar to other recent
studies [37,42].
Here we present evidence for a central role of LSECs in the
initial uptake of polyomavirus from blood. Despite the fact that
mouse is not a permissive host for BKV and JCV, LSEC endocytic
functions and receptor expression are highly similar between
mammalian species, including humans [10,11,15,43–45], arguing
that human LSECs are likely to also take up these virus particles
when they first appear in the circulation. In addition, we found
that the BK- and JC-VLPs rapidly distributed to a distinct
population of endothelial cells in kidney medulla. These endothe-
lial cells also avidly endocytosed a scavenger receptor ligand,
suggesting that they represent a subpopulation of endothelial cells
with extraordinarily high endocytic activity.
Materials and Methods
Ethics statement
All animal experiments were approved by the Norwegian
National Animal Research Authority (NARA) (approval IDs: ID-
1912, ID-2775, ID-4720, ID-4894). The substances used for
mouse anesthesia were either 1) a combination of tiletamine
hydrochloride (Zoletil forte vet, Virbac) and xylazine (Narcoxyl
vet, Intervet), or 2) a combination of fentanyl/fluanisone
(Hypnorm, VetaPharma) and midazolam (Dormicum, Roche).
The mice were euthanized in 100% CO2, while anesthetized as
described above.
Animals
Wild-type C57BL/6 male mice were obtained from Charles
River laboratory (France). Mannose-receptor knock-out (MR-/-)
C57BL/6 mice [46] were kindly provided by Professor Michel
Nussenzweig, The Rockefeller University, New York, NY. The
MR-/- status was tested by polymerase chain reaction [46]. The
animals were housed in rooms specially designed for mice, with
12 h/12 h day-night cycle, and free access to water and food
(standard chow, Scanbur BK, Nittedal, Norway).
Chemicals and reagents
Liberase TM (collagenase) was from Roche Applied Science
(Oslo, Norway), IodogenTM from Pierce Chemicals (Rockford, IL),
and carrier-free Na125I from PerkinElmer Norge AS (Oslo,
Norway). Bovine serum albumin was from MP Biomedicals
(Solon, OH), bovine collagen type I (Vitrogen 100) from Cohesion
Technologies (Palo Alto, CA), and PercollTM and PD-10 columns
(Sephadex G-25) from GE Healthcare (Uppsala, Sweden). Roswell
Park Memorial Institute (RPMI) 1640 cell culture medium
(supplemented with 20 mM sodium bicarbonate, 0.006% penicil-
lin, and 0.01% streptomycin) was from Sigma-Aldrich (St Louis,
MO), and Falcon cell culture plates from BD Biosciences (San
Jose, CA). Draq5 was from Biostatus limited (Leicestershire, UK).
Antibodies and suppliers are listed in Table 1.
Cells
Hepatic non-parenchymal liver cells (NPCs) were prepared by
collagenase (Liberase) perfusion of mouse livers, followed by low-
speed differential centrifugation to remove hepatocytes, and
density sedimentation of the NPCs on 25%–45% Percoll gradients
to collect LSEC and Kupffer cells, as described in [47]. Purified
LSECs (.90% purity) were obtained after a panning step (8 min,
37uC), to remove Kupffer cells. Primary cell cultures were
established on glass cover slides (mixed LSEC and Kupffer cells),
and in Falcon plates (LSECs), pre-coated with 2.7 mg/ml collagen
type I and maintained in serum-free RPMI-1640 medium at 37uC
at 5% CO2. The cultures were washed 40 min after seeding, and
allowed to continue spreading for approximately 1 h before use.
Seeding of 36105 LSEC/cm2 gave confluent monolayers, with
approximately 1.56105 cells per cm2.
Virus-like particles (VLPs)
BK- and JC-VLPs were prepared as described previously [48].
Briefly, BK- and JC-VLPs were isolated from Sf9 insect cells
infected with recombinant baculovirus encoding Dunlop BK-VP1
or Mad-1 JC-VP1 capsid protein. Recombinant baculoviruses
containing PML variants of JC VP1 sequences L55F or S269F
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were obtained by site specific mutagenesis PCR using the
following primers: L55F-Fwd (59-ACC CAG ATG AGC ATT
TTA GGG GTT TTA G-39) and L55F-Rev (59-CTA AAA CCC
CTA AAA TGC TCA TCT GGG T-39), S269F-Fwd (59-TAA
CAG ATC TGG TTT CCA GCA GTG GAG A-39) and S269F-
Rev (59-TCT CCA CTG CTG GAA ACC AGA TCT GTT A-
39), respectively. Infected Sf9 cells were disrupted by sonication
and glass mortar and pestle treatment. VLPs were purified from
cellular lysate by CsCl gradient and stored in buffer consisting of
150 mM NaCl, 10 mM Tris-HCl pH 7.4 and 1.0 mM CaCl2.
The 3-dimensional structure and integrity of VLPs was confirmed
by transmission electron microscopy (Figure 1). In short, JC-
VLPs or BK-VLPs in 0.9% NaCl were placed on discharged
pallodium coated mesh grids for 2 min; then washed twice with
double distilled water, and once with freshly made 2% uranyl
acetate. Another drop of 2% uranyl acetate was added for 10 sec.
The grids were gently washed on drops of double distilled water
and air dried before electron microscopy. The images were
recorded in a FEI CM100 TEM transmission electron microscope
(FEI, OR, USA), operating at 80 kV, and equipped with Veleta
digital CCD camera (Olympus, Germany).
Ligand labeling procedures
VLPs in phosphate buffered saline (PBS) were labeled with
carrier-free Na125I, using Iodogen as described by the manufac-
turer (Pierce Chemicals), and separated from unbound 125I on a
PD-10 column. The resulting specific radioactivity was approxi-
mately 4276106 cpm per mg protein. 125I-VLPs for injections
were mixed with 0.9% NaCl to a final concentration of
approximately 0.5 mg protein/100 ml ( = dose injected per mouse).
Fluorescein isothiocyanate-labeled formaldehyde-denatured bo-
vine serum albumin (FITC-FSA) was prepared by incubating FSA
and FITC in sodium carbonate buffer (0.5 mol/L, pH 9.5) at a
protein-dye ratio of 4:1 at 4uC overnight, and dialyzed against
PBS.
Blood clearance and organ distribution of radiolabeled
VLPs
125I-BK-VLP, 125I-JC-VLP, 125I-JC-VLPL55F, or
125I-JC-
VLPS269F (approximately 0.5 mg protein) were injected into the
tail vein of anaesthetized mice (n = 3–5 per group). Immediately
thereafter blood samples (5 ml) were collected over short time
intervals from the tail tip, mixed with 0.3 ml of 13 mM citric acid,
after which 0.3 ml 2% bovine serum albumin in water and 0.6 mL
of 20% (wt/vol) trichloroacetic acid were added to the samples to
precipitate non-degraded protein. Acid-soluble radioactivity rep-
resented degraded ligand [25]. To test if the higher doses of VLPs
injected for immunohistochemistry would influence blood clear-
ance and organ distribution, non-labeled JC-VLPs (15 mg = dose
used for immunohistochemistry) were injected simultaneously with
125I-JC-VLPs (0.5 mg). This did not change the blood clearance or
organ distribution pattern of the radiolabeled ligand. In some
Table 1. Antibodies and lectins used in the study.
Antigen Host Clone Isotype Source Dilution
BK-VP1 Rabbit Antiserum - [53] 1:1600
Mannose receptor (CD206) Goat Polyclonal IgG R&D Systems, AF2534 1 mg/ml
F4/80 Rat Cl:A31 IgG2b AbD Serotec, MCA497G 10 mg/ml
CD31 Rat MEC13.3 IgG2a Biolegend, 102502 5 mg/ml
CD68 Rat FA-11 IgG2a Abcam, ab53444 10 mg/ml
CD163 Rat ED2 IgG1 AbD Serotec, MCA342GA 10 mg/ml
Meca 32 Rat - IgG2a Antibodies online ABIN298904 10 mg/ml
Biotinylated Sambucus nigra agglutinin - - - Vector Laboratories B-1305 10 mg/ml
Biotinylated Maackia amurensis II hemagglutinin - - - Vector Laboratories B-1265 10 mg/ml
Secondary antibodies: Alexa488-, Alexa546-, or Alexa555- anti-rat, anti-rabbit or anti-goat IgG (H+L), raised in donkey, goat, or rabbit, all diluted 1:500 (Life Technologies;
Catalog No: A11006, A11008, A11055, A11081, A11010, A21431, A21434, A21428).
Positive lectin labeling was visualized by Alexa555-streptavidin, diluted 1:200 (Life Technologies; Catalog No S-21381).
doi:10.1371/journal.pone.0111762.t001
Figure 1. Electron microscopy of BK- and JC-virus like particles (VLPs). The figure show transmission electron micrographs of negatively
stained BK- and JC-VLPs constructed from BK-VP1 or JC-VP1 proteins: A) BK-VP1 VLPs (Dunlop strain); B) JC-VP1-Mad-1 VLPs; C) JC-VP1-L55F VLPs; D)
JC-VP1-S269F VLPs. Scale bars: 200 nm.
doi:10.1371/journal.pone.0111762.g001
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animals FSA (0.8 mg protein in100 ml 0.9% NaCl) was injected
immediately before the administration of radiolabeled ligand to
check for inhibition of blood clearance.
At the end of the monitoring period (10 min or 60 min) the
anaesthetized animals were euthanized with 100% CO2. The
abdomens and thoraces were opened, and the animals were
perfused via the left cardiac ventricle (outlet via the right atrium)
with PBS to remove free tracer from the vasculature before the
organs were excised and analyzed for radioactivity. The amount of
tracer recovered was considered the sum of radioactivity of
individual organs and carcass without organs.
Hepatocellular distribution of 125I-VLPs
125I-BK-VLP, 125I-JC-VLP, 125I-JC-VLPL55F, or
125I-JC-
VLPS269F (approximately 0.5 mg protein) was injected into the tail
vein of anaesthetized mice (n = 3 per group). Ten minutes after the
injection the animals were euthanized with 100% CO2 and liver
cells isolated by collagenase perfusion of liver via the portal vein,
before separating the dispersed liver cells into hepatocytes and
NPCs [47]. All steps during cell isolation and separation, except
the liver perfusion step, were carried out on ice/below 4uC.
Radioactivity in the hepatocyte and NPC fractions was measured
in a Packard Gamma Counter. Cell numbers were assessed by cell
counting in a hemocytometer.
Figure 2. Blood clearance and subsequent in vivo degradation of BK- and JC-virus like particles (VLPs). Mice were injected
intravenously with approximately 0.5 mg of 125I-BK-VLPs (n = 3; A, B), or 125I-JC-VLPs (n = 5; C, D), and blood samples taken at the indicated time points
and analyzed for 125I-labeled degradation products and intact ligand [15]. Panels A and C show decrease of intact ligand in blood as a function of
time. Panels B and D show increase in degradation products released into the blood with time. Results are given as cpm per ml blood. Different
symbols refer to separate animals. cpm, counts per minute. The slope of line drawn in panel D represents the average rate of release of degradation
products in the 10–30 min period after ligand injection where this release followed approximate first order kinetics.
doi:10.1371/journal.pone.0111762.g002
Table 2. Rate of blood clearance of BK- or JC virus-like particles (VLPs) in mouse.




125I-BK-VLP 2.0660.90 42.8569.51 39.1866.30 60.8266.30
125I-JC-VLP 1.1760.11 46.08637.20 75.7063.84 24.3063.84
125I-JC-VLPL55F 1.2860.26 25.16612.76 79.2162.75 20.8062.75
125I-JC-VLPS269F 1.0660.30 41.8167.62 70.92611.60 29.08611.60
125I-BK-VLP+FSA 0.9160.71 33.567.69 56.17626.73 43.89626.73
125I-JC-VLP+FSA 1.0460.11 31.1368.50 85.6262.78 14.3762.78
N = 3 in all groups except 125I-JC-VLP where n = 5. Results are given as mean 6 SD.
*t1/2 a and t1/2 b were calculated as described in [52].
doi:10.1371/journal.pone.0111762.t002
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Immunohistochemistry and lectin histochemistry
Non-labeled BK-VLPs or JC-VLPs (13–18 mg protein per
mouse) was injected into the tail vein of anaesthetized mice
(n = 3–5 per ligand). The animals were euthanized after 7–15 min,
then perfused with PBS through the left cardiac ventricle to
remove blood and thereafter with 4% paraformaldehyde (PFA) in
PBS with 0.02 M sucrose. The perfusion fixed tissues were
dehydrated, paraffin embedded and sectioned. In some animals,
FITC-FSA (50 mg protein per mouse) was injected into the tail
vein 5 min after injection of 10 mg JC-VLP, JC-VLPL55F, or JC-
VLPS269F, and the mice euthanized 10 min thereafter, before
perfusion fixation and tissue preparation for immunohistochem-
istry as described above. Antigen retrieval was achieved by 30 min
microwaving in citrate buffer, pH 6. Blocking buffer was 5% goat
serum or 1% BSA in TBS and 0.05 M Tween 20, pH 8.4.
Sections were incubated overnight (37uC) with primary antibodies
(Table 1) or non-immune IgG diluted in blocking buffer, washed
and incubated with secondary antibody in blocking buffer for 1 h
at room temperature. Nuclear stain was Draq5 (diluted 1:1000 in
PBS). Sections were analysed in a Zeiss LSM 510 confocal laser
scanning microscope (Carl Zeiss, Germany).
Lectin histochemistry on tissue sections. Biotinylated
lectins, Sambuccus nigra agglutinin (SNA), and Maackia amur-
ensis hemagglutinin (MAH), were purchased from Vector Labo-
Figure 3. Anatomical distribution of 125I-labelled BK- and JC-VLPs. Mice were injected intravenously with 125I-labelled BK-VLPs (A) or JC-VLPs
(B), euthanized after 10 min (black bars; n = 3) or 60 min (grey bars; n = 3 in A; n = 5 in B), and organs and tissues analyzed for radioactivity. The mice
used in the circulatory half-life study (Figure 2) were included in this anatomical distribution study (60 min values). Total recovered radioactivity in all
tissues at the given time points was taken as 100%. Error bars represent SEM. *Statistically significant difference (p,0.01) between tissue radioactivity
at 10 min versus 60 min. # Brain radioactivity was measured at 60 min, only. GI tract, gastrointestinal tract (stomach and intestines including
mesenterium).
doi:10.1371/journal.pone.0111762.g003
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ratories (Vector Laboratories Inc, CA, USA), and Alexa555-
streptavidin from Life Technologies (Table 1). SNA recognizes
alpha(2,6)-linked sialic acids, and MAH recognizes alpha(2,3)-
linked sialic acids [49]. Lectin labeling of paraffin tissue sections of
liver, kidney and spleen were done according to the instructions
from Vector Laboratories.
Endocytosis experiments in isolated liver cells
Confocal microscopy. Primary NPC cultures, enriched in
LSECs with approximately 10–20% Kupffer cells, were estab-
lished on collagen coated glass cover slides. Since LSECs rapidly
lose their in vivo uptake functions after isolation [50] endocytosis
experiments were performed under serum-free conditions within
4 h of plating. Antibody markers for LSECs and Kupffer cells are
listed in Table 1. The cells were incubated with BK-VLP, JC-
VLP, or BKV for 30 min-1 h, washed, fixed in 4% PFA in PBS/
0.02 M sucrose for 15 min, immune labeled, and subjected to
confocal laser scanning microscopy.
Immune EM. Purified LSECs (approximately 1.5 million
cells in 8 cm2 Falcon wells) were incubated with 2.06E+10
genomic equivalents of CsCl gradient purified BKV in 1 ml
serum-free RPMI 1640 medium for 2 h, washed in PBS and fixed
in 4% formaldehyde in 200 mM Hepes buffer, pH 7.5, overnight,
embedded in gelatin and 2.3 M sucrose, and snap frozen in liquid
nitrogen. Immune labeling of ultrathin cryosections was per-
formed as described [51]. Positive BK-VP1 labeling was detected
by protein A-conjugated 10 nm gold complexes. The dried
sections were examined in a JOEL JEM 1010 transmission
electron microscope (JOEL, Tokyo, Japan) operating at 80 kV.
Control experiments were included in parallel by omission of the
primary antibody.
Statistics and pharmacokinetic analyses
The statistical calculations (Mann-Whitney U test, ANOVA
two-way analysis of variance) were performed with GraphPad
Prism (GraphPad Software Inc. San Diego, CA). Clearance
kinetics were analyzed as described [52].
Results
Removal of blood-borne BK- and JC-virus like particles
(VLPs) was rapid, with JC-VLPs being cleared more
efficiently than BK-VLPs
BK-VLPs and JC-VLPs were radiolabeled and injected via the
tail vein. The rate of blood clearance of 125I-BK-VLP and 125I-JC-
VLP is shown in Figure 2A, C. Semi-logarithmic decay plots
revealed a biphasic pattern of elimination from blood, with an
initial rapid t1/2 a of 1–2 min for both ligands (Table 2). During
this early phase the uptake from blood of 125I-BK-VLP and 125I-
JC-VLP were 39% and 76%, respectively, revealing a considerably
more effective initial blood clearance of JC-VLP than BK-VLP.
After 60 min approximately 30% of the BK-VLP associated
radioactivity was still in the circulation (Figure 2A), suggesting
that BK-VLPs may interact with some unknown blood factor(s)
protecting them from being taken up. In contrast, only 10% of JC-
VLP associated radioactivity was left in blood after 30 min
(Figure 2C).
Intracellular degradation of 125I-labeled proteins normally
generates 125I-tagged low molecular mass degradation products
that are released from the cells, and can be measured in blood
following trichloroacetic precipitation of intact proteins [25]. Acid
soluble 125I-degradation products appeared in blood 10 min after
injection of the radiolabeled VLPs (Figure 2B, D). In agreement
with the more efficient blood clearance of JC-VLPs, more
degradation products were released to blood after injection of
125I-JC-VLPs than after 125I-BK-VLP injection in the 60 min
monitoring period.
BK- and JC-VLPs distributed to liver, with a minor uptake
in spleen and kidney
To minimize the escape of label from the site of uptake due to
intracellular ligand degradation, organ distribution of radiolabeled
ligands was measured already 10 min after injection. At this point,
the majority of the 125I-BK-VLP (48%) and 125I-JC-VLP (60%)
associated radioactivity was found in liver, whereas spleen and
kidneys contained 9% and 5% of the 125I-BK-VLPs, and 12% and
5% of the 125I-JC-VLPs, respectively (Figure 3).
To investigate the kinetics of organ distribution the VLPs
following administration, the liver-associated radioactivity was
followed from 10 to 60 min after injection. For 125I-BK-VLP,
liver-associated radioactivity decreased only slightly (Figure 3A),
which may reflect that cellular uptake and degradation overlap
due to the slower blood clearance of BK-VLP. In contrast, for 125I-
JC-VLP, the liver-associated radioactivity decreased from 60% to
30% of total recovered radioactivity during the same time period
(Figure 3B), indicating effective hepatocellular degradation of
JC-VLP. A corresponding increase of radioactivity in the
gastrointestinal tract (including mesenterium and lymph nodes)
and the rest of carcass in the same period was judged to be caused
by redistribution of degradation products, which is commonly
noted following administration of 125I-labeled ligands [26].
To measure the relative contribution of different liver cells in
the VLP uptake mice injected intravenously with 125I-labelled BK-
or JC-VLPs were sacrificed after 10 min for liver cell isolation and
separation into hepatocytes and NPCs, the latter consisting mainly
of LSECs and some Kupffer cells, as described in Materials and
Table 3. Liver uptake of BK- and JC-VLPs from blood takes place in NPCs.
Ratio of radioactivity in NPCs versus hepatocytes after
injection of 125I-BK-VLPs
Ratio of radioactivity in NPCs versus hepatocytes after
injection of 125I-JC-VLPs
Mouse 1 6.5: 1 Mouse 1 22.1: 1
Mouse 2 6.3: 1 Mouse 2 29.8: 1
Mouse 3 26.5: 1 Mouse 3 22.3: 1
Average 13.1: 1 Average 24.8: 1
The mice were injected intravenously with 125I-labelled VLPs, approximately 0.5 mg per animal, and euthanized after 10 min. Liver cells were then isolated by in situ perfusion
with collagenase, and separated by low-speed differential centrifugation and subsequent density centrifugation on a Percoll gradient [47]. Radioactivity (counts per minute)
was measured in the purified hepatocyte fraction, and in the NPC fraction enriched in LSECs and Kupffer cells.
doi:10.1371/journal.pone.0111762.t003
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Figure 4. Liver cell distribution of BK- and JC-VLPs after uptake from blood. Panels A–F: Mouse livers were perfusion fixed 15 min after
intravenous injection of BK-VLPs (A–C), or JC-VLPs (D–F). Paraffin embedded tissue sections were double immune labeled using a rabbit antiserum
against BK-VP1 [53], and antibodies against the mannose receptor (MR), which is an LSEC marker in mouse liver [26], or F4/80 (Kupffer cell marker).
Antibodies are listed in Table 1. The VP1 staining (green), indicative of BK-/JC-VLP uptake, showed a typical LSEC pattern (A, D, overview; B, E, close
ups), as evidenced by similar localization of green VP1 and red MR staining along the sinusoids (arrowheads in B, E; overlap of red and green
fluorescence is shown in yellow). Some BK- and JC-VLP uptake was also observed in F4/80 positive (red) Kupffer cells (arrows in C, F). PV, portal vein; S,
sinusoid; Hn, nucleus of hepatocyte. Panels G–L: In G–L, FITC-labeled formaldehyde-denatured serum albumin (FITC-FSA) was injected into the tail
vein 5 min after intravenous injection of JC-VLPs to functionally label the endothelium of the liver sinusoids [54,62]. Ten min thereafter the animals
were euthanized, tissues perfusion fixed, paraffin embedded and prepared for immune histochemistry. Panels G-I show the distribution of FITC-FSA
(green) and JC-VLP (red, arrowheads) in liver sinusoids (s). Panels J–L show similar distribution of FITC-FSA (green) and MR expression (red) in the
sinusoids, s.
doi:10.1371/journal.pone.0111762.g004
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Methods. The liver radioactivity was mainly associated with the
NPC fraction (Table 3).
The liver uptake of BK- and JC-VLPs took place mainly in
the sinusoidal endothelium
To identify the cellular distribution of VLPs in liver, non-labeled
BK-VLPs or JC-VLPs were injected intravenously, and organs
harvested after 7–15 min, fixed, paraffin embedded, and pro-
cessed for immunohistochemistry using a rabbit antiserum against
BK-VP1 [53] (Table 1) that cross-reacts with JC-VP1.
In liver, BK- and JC-VLP staining was observed along the
hepatic sinusoids, colocalizing with cells expressing the mannose
receptor (LSEC marker) (Figure 4A, B, D, E; Figure S1), or in
cells that had endocytosed the scavenger receptor ligand FITC-
FSA, a functional LSEC marker [30,54] (Figure 4G–I). In
C57BL/6 mouse liver, the mannose receptor is expressed in
LSECs but not in Kupffer cells [26]. Some uptake of BK- and JC-
VLPs was also seen in F4/80 positive Kupffer cells (Figure 4C,
F), whereas no BK- or JC-VLP positive staining was observed in
hepatocytes, endothelial cells of portal venules or arteries, bile
ducts or other liver structures.
To characterize in greater detail the cells involved in the hepatic
uptake of polyomavirus, freshly isolated liver NPCs were
incubated with infectious BKV, non-labeled BK-VLPs, or JC-
VLPs for various time periods (30 min–1 h), immune labeled and
subjected to confocal microscopy (Figure 5A–F). Both LSECs
and Kupffer cells took up BK- and JC-VLPs, and BKV in vitro.
Results were confirmed by double labeling with anti-BK-VP1
antiserum and antibodies against the mannose receptor (LSEC
marker in liver [26]; Figure 5A–C; Figure S2) or CD68
(Kupffer cell marker; Figure 5D–F). Cryo-immune electron
microscopy of purified LSEC cultures incubated with infectious
BKV for 2 h showed virus accumulation in membrane-bound
compartments (Figure 5G, H).
Figure 5. In vitro endocytosis of BK- and JC-VLPs, and BK virions in liver sinusoidal cells. Freshly isolated non-parenchymal liver cells
(mixed LSEC and Kupffer cell cultures) were incubated at 37uC for 30 min with BK virions (A, D), or for 1 h with 10 mg/ml BK-VLPs (B, E), or JC-VLPs (C,
F), fixed, and double immune labeled with a rabbit anti-BK-VP1 antiserum (red fluorescence) and antibodies against the mannose receptor (MR; LSEC
marker; shown in green), or CD68 (Kupffer cell marker; green). Antibodies are listed in Table 1. Uptake of BK virions and BK-/JC-VLPs was observed
both in isolated LSECs (arrows, A–C) and Kupffer cells (arrow heads, D–F). Panels G–H: Cryo-immune electron microscopy of BK virion uptake in LSEC
membrane-bound vesicles. Purified LSEC cultures were incubated with BK virions for 2 h at 37uC. Positive BK-VP1 staining was visualized by protein-
A-10 nm gold particles (black dots). Arrowheads points to vesicular membranes, and arrows to virus particles. Nu, nucleus.
doi:10.1371/journal.pone.0111762.g005
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Figure 6. Blood clearance and organ distribution of mutant JC-VLPs. Mice were injected intravenously with 125I-JC-VLPL55F (n = 3, A–B), or
125I-JC-VLPS269F (n = 3, C–D), and blood samples taken at the indicated time points and analyzed for
125I-labeled degradation products and intact
ligand [15]. Panels A and C show the decrease of intact ligand in blood as a function of time. Panels B and D show the increase in degradation
products released into the blood with time. Different symbols refer to separate animals, and cpm to counts per minute. The slopes of the lines drawn
in B and D represent the average release rate of degradation products in the 10–30 min period after ligand injection where this release followed
approximate first order kinetics. E) Tissue distribution 60 min post injection. The animals in A–D were sacrificed after 60 min, and organs and tissues
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Liver uptake of blood-borne VLPs was not dependent on
sialic acids
It is reported that BKV and JCV enter their natural host cells
via carbohydrate receptors [55]. While BKV binds to alpha(2,3)-
linked sialic acids on (for instance) gangliosides [56], JCV binds to
alpha(2,6)-linked glycan lactoseries tetrasaccharide c (LSTc) [57].
To test whether blood clearance of JCV in mice is dependent on
alpha(2,6)-linked sialic acids, we examined the elimination from
blood of two JC-VLP variants occurring frequently in PML
patients, namely JC-VLPL55F and JC-VLPS269F (Figure 6A–D,
Table 2), which had been shown to no longer hemagglutinate red
blood cells and to have lost their respective sialic acid receptor
binding properties [58]. These VLPs were constructed from
mutant forms of the JCV capsid protein VP1, in which one amino
acid in the sialic acid binding loop of VP1 had been substituted.
The data show that 125I-JC-VLPL55F and
125I-JC-VLPS269F were
removed from the circulation in a similar manner as the JC-VLPs
made from Mad-1 JC-VP1 (named here as JC-VLP) (Table 2).
After 60 min nearly all 125I-JC-VLPL55F, and 80% of the
125I-JC-
VLPS269F were eliminated from blood (Figure 6A, C). Similarly
to the JC-VLPs, acid soluble 125I-degradation products appeared
in the circulation already after 10 min (Figure 6B, D).
Organ distribution of 125I-JC-VLPL55F and
125I-JC-VLPS269F
60 min post injection (Figure 6E) was similar to that of JC-VLP
(Figure 3B), with the highest radioactivity measured in liver.
Notably, radioactivity in the brain was negligible. Hepatocellular
distribution studies, monitoring radioactivity in hepatocytes and
NPCs separated10 min after injection of radiolabeled ligands,
showed that the uptake of 125I-JC-VLPL55F and
125I-JC-VLPS269F
was predominantly in the NPC fraction (Figure 6F). Immuno-
histochemistry revealed an LSEC-like pattern of distribution along
the sinusoids (Figure 6G), as with JC-VLP (Figure 4). Of note,
lectin histochemistry for SNA and MAH revealed that all hepatic
endothelia expressed alpha(2,6)-linked-sialic acids and alpha(2,3)-
linked sialic acids (Figure S3), whereas BK-VLPs and JC-VLPs
(Mad-1 and mutants) distributed only to sinusoids (Figures 4,
and 6), suggesting that these sialic acids are not essential for liver
uptake.
The scavenger receptor ligand formaldehyde-denatured
serum albumin (FSA) reduced the rate of intracellular
degradation of JC-VLP, but did not interfere with VLP
uptake in liver
LSECs mediate their effective blood clearance of most known
ligands via a limited set of endocytosis receptors of broad ligand
specificity [10]. To study if LSEC scavenger receptors were
involved in the uptake of circulating BK-VLPs or JC-VLPs, a high
dose of FSA (0.8 mg/mouse) was injected immediately prior to the
injection of 125I-labeled VLPs. FSA is a soluble scavenger receptor
ligand and is reported to distribute mainly to the LSEC after
intravenous administration [59]. No effect was observed on the
blood clearance kinetics of 125I-BK-VLP (Table 2) or 125I-JC-
VLP (Figure S4, Table 2). However, the release of 125I-JC-VLP
degradation products to the blood (Figure S4-B) was slightly
reduced by simultaneous FSA injection compared to injection of
only 125I-JC-VLP (Figure 2D). This resulted in significantly more
liver-associated radioactivity after 60 min (Figure S4-C) com-
pared to injection of 125I-JC-VLP alone (Figure 3B), suggesting
that metabolic turnover, but not uptake was rate limiting following
targeting of the same cell by FSA and JC-VLP.
To investigate if the clearance of the VLPs was mediated by the
mannose receptor, a C-type lectin with broad ligand binding
properties and highly expressed in mouse, rat and human LSECs
[15,26,43], mannose receptor deficient mice [46] were injected
with 125I-JC-VLPs (Figure S5). These mice showed similar
clearance and organ distribution of JC-VLPs as wild type mice
(Figures 2B, 3B), indicating that the rapid JC-VLP blood
clearance was not mediated by the mannose receptor pathway.
Extrahepatic clearance of blood-borne BK- and JC-VLPs
took place in endothelial cells of kidney vasa recta
segments, and in reticuloendothelial cells of spleen red
pulp marginal zone
The organ distribution studies of radiolabelled ligands showed a
minor, but significant uptake in kidney and spleen. This prompted
us to examine the VLP uptake in these organs by immunohisto-
chemistry.
In kidney, BK- and JC-VLP uptake was specifically associated
with microvessels of renal medulla (Figure 7A–D). Staining
intensity of positive vessels was distinct and strong. However,
VLP uptake was not seen in all medullary vessels, suggesting
discrimination between different segments of vasa recta. Most of
the VLP staining did not overlap with staining for Meca 32 (syn.
PV-1, a component of fenestral diaphragms) (Figure 8A–F),
which label endothelial cells of fenestrated segments of vasa recta
[60,61]. This suggests that the BK- and JC-VLP uptake took place
in non-fenestrated endothelial cells, which are located in
descending segments of the vasa recta. Endothelial cells that took
up VLPs also rapidly and selectively endocytosed FITC-FSA
(Figure 8G–I), which in liver is a functional marker for LSECs
[30,54,59,62]. FITC-FSA uptake in kidney was seen in medullary
vessels only, and the uptake showed little overlap with Meca 32
staining (Figure 8J–L). The distribution pattern of JC-VLP and
FITC-FSA in kidney medullary vessels almost completely over-
lapped, suggesting the presence of a highly endocytically active
endothelium in these vessels.
BK- and JC-VLPs also distributed to the transitional epithelium
of the renal pelvis (Figure 7G, H), whereas glomeruli and tubular
structures of the nephron were negative in all mice (Figure 7E, F)
except for one animal injected with BK-VLP, which showed
positive staining of a few glomeruli (not shown). Lectin
histochemistry for SNA and MAH showed positive labeling of
all endothelia in kidney (Figure S3).
In spleen, the BK- and JC-VLPs distributed to the marginal
zone that separates the lymphocyte rich white pulp from the red
pulp (Figure 9, and Figure S6). The VP1 labeling showed a
net-like staining pattern in this region. Double immune labeling
for VP1 and the macrophage marker F4/80 (Figure 9A–C), or
CD31 (Figure 9D–F), which is expressed by many endothelial
cells, revealed scattered co-localisation of VLPs with CD31 and
F4/80 positive cells, suggesting that the marginal zone reticulo-
endothelial network of macrophages and endothelial cells are
involved in VLP uptake in the spleen. Staining for the macrophage
analyzed for radioactivity. Recovered radioactivity in all tissues at this time point was taken as 100%. Error bars represent SEM. GI tract,
gastrointestinal tract (stomach and intestines including mesenterium); U bladder, urine bladder. F) Hepatocellular distribution (6SD) of 125I-labeled
JC-VLP mutants 10 min after intravenous injection; liver tissue was dispersed by collagenase perfusion, and radioactivity was measured in hepatocyte
and non-parenchymal cell (NPC) fractions, respectively. G) Cellular distribution of JC-VLPS269F (anti-VP1 staining) 15 min after VLP injection. Uptake of
JC-VLPS269F (red fluorescence; arrowheads) is seen along the sinusoids (s).
doi:10.1371/journal.pone.0111762.g006
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antigen CD163 [63] did not co-localize with VP1 staining
(Figure 9G–I), indicating VLP uptake only in subsets of spleen
red pulp macrophages. Some of the JC-VLP uptake in spleen co-
localized with FITC-FSA which also distributed to the reticulo-
endothelium of the spleen red pulp marginal zone (Figure 9J–L).
Discussion
Clinical models of BKV and JCV infection demonstrating
replicative pathologies with close correlation to nephropathy,
cystitis or multifocal leukoencephalopathy are currently lacking.
However, these viruses are recognized and taken up by cells from
non-permissive hosts, including mice [37,42], allowing us to study
their cellular site of uptake in a mouse model. Primary infection
with these viruses is believed to occur during early childhood, but
their initial infection route or organ distribution is not well known.
Using well characterized VLPs, we present evidence that LSECs
are highly effective in clearing a large fraction of blood-borne
BKV and JCV particles. Moreover, we observed that BK and JC
VLPs are efficiently taken up in some microvessels of renal
medulla and the spleen marginal zone reticuloendothelium. By
effectively acting as a virion sink in the absence of specific
antibodies, LSECs may play a key role in the mostly asymptomatic
course of primary BKV and JCV infection, leaving only little virus
to escape and reach the renal medulla (and possibly the spleen), an
important site of BKV and JCV persistence [40,41]. LSECs
represent a highly specialized type of scavenger endothelium
preserved across different vertebrate species including rodents and
humans [10,45]. Several signature characteristics are the same in
LSECs across mammals: Cell morphology and endocytosis
receptor expression in human LSECs are identical to that of
rodents and pig [10,11,15,43,44], and the scavenger function of
rat, mouse, and pig LSECs is strikingly similar [64]. It is therefore
likely that our present findings on the efficient LSEC endocytosis
of polyoma VLPs in mice reflect the fate of these viruses also in
human livers.
The observed biphasic pattern of polyoma VLP clearance from
blood, with a rapid a-phase and a slower b-phase is comparable to
the clearance kinetics of many macromolecules and colloids that
are efficiently eliminated via receptor-mediated endocytosis in the
LSECs [15,25,26]. There were, nevertheless, some interesting
differences between the BK-VLP and JC-VLP clearance patterns.
While JC-VLPs were almost completely removed from the
circulation within 10 minutes, the a-phase was less dominant in
the elimination of BK-VLPs, suggesting a rapid saturation of BK
binding/uptake receptors or interaction of BK-VLPs with blood
factors (proteins or cells), delaying the blood clearance. Interest-
ingly, in their natural host cells BKV is reported to be internalized
via caveolin-mediated endocytosis whereas JCV enters via
clathrin-mediated endocytosis [36]. This could also be an
explanation of our results, because LSECs have well-developed
clathrin-mediated endocytosis machinery, and rely heavily on this
type of endocytosis to maintain their signature scavenging activity
[34,65].
Our hypothesis is that LSECs protect against virus infections,
due to their very efficient endocytosis and high catabolic activity
which rapidly destroy internalized material [10]. Our in vivo data
indicate that at least JC-VLPs are rapidly degraded in the liver, as
reported for other macromolecules taken up by the LSECs
[10,26]. In this context, it is of interest to note that BKV viremia is
readily detectable in transplant patients with BKV-associated
diseases, while JCV viremia is only rarely detected in patients with
JCV-associated diseases [66] [67].
However, degradation of VLPs is not a proof of cellular
destruction of infective virus, and to establish whether BKV or
JCV uptake in LSECs will lead to destruction of all internalized
virus particles, or allow for endosomal escape and intracellular
Figure 7. Kidney distribution of intravenously administered
BK- and JC-VLPs. Mouse tissues were perfusion fixed 7 or 15 min
after injection of BK-VLPs (A, C, E, G), or JC-VLPs (B, D, F, H). Paraffin
sections were labeled using a rabbit anti-BK-VP1 antiserum [53]. VP1-
labeling was visualized using HRP polymer/DAB reaction (brown color),
or Alexa488-goat-anti-rabbit (green fluorescence). Specific uptake of
VLPs was seen in the endothelial lining of microvessels in kidney
medulla (arrows in A–D; with arrowheads in D pointing to blood filled
medullary capillaries), whereas glomeruli (E, F), and tubular structures
were negative (A–F). Epithelial cells in the transitional epithelium of
renal pelvis also showed positive VP1 staining (arrows in G, H). g,
glomerulus; pt, proximal tubulus; dt, distal tubulus.
doi:10.1371/journal.pone.0111762.g007
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Figure 8. Polyoma VLP and FITC-FSA uptake in renal medullary endothelial cells. Panels A–F: Mouse tissues were perfusion fixed 7 min
after intravenous injection of BK-VLP (A–C), or JC-VLP (D–F), and paraffin sections double immune labeled with anti-BK-VP1 (red) and anti-Meca 32
(green). Panels A–C: Arrows indicate endothelial uptake of BK-VLPs in Meca 32 negative vessels, and arrow heads to BK-VLP uptake in Meca 32
positive vessels. Panels D–F: Arrows indicate endothelial uptake of JC-VLPs in Meca 32 negative vessels, and arrow heads to JC-VLP uptake in Meca 32
positive vessels. Most BK-VLP or JC-VLP-positive vessels were Meca 32 negative or showed only weak Meca32 staining. Panels G–L: Tail vein injection
of JC-VLPs was followed by injection of the scavenger receptor ligand FITC-FSA in the opposite tail vein and tissues perfusion fixed 15 min after the
VLP administration. Paraffin sections were immune labeled with either anti-BK-VP1 (red; G–I) or anti-Meca 32 (red; J–L). G–I) The JC-VLP uptake in
medullary vessel endothelia totally overlapped with FITC-FSA uptake (arrows). J–L) FITC-FSA uptake occurred mainly in Meca 32 negative vessels.
doi:10.1371/journal.pone.0111762.g008
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replication of a fraction of the internalized virions would require
further studies. However, in vitro model systems are currently
lacking that recapitulate the known in vivo physiological activity of
human LSECs, hence impeding such studies.
In addition to a major hepatic uptake, a minor, but significant
BK-/JC-VLP uptake was also measured in spleen red pulp and
kidney medulla. The spleen red pulp is known to harbor scavenger
type of endothelia [10] and could thereby serve as a secondary site
of BKV and JCV clearance. Of note, the rapid and specific uptake
of polyoma virus or VLPs in kidney medullary vessels has to our
knowledge not been reported before, and may reveal novel insights
into the infection route of BKV and JCV. It is notable, however,
that clinical recommendations emphasize the importance of
medullary tissue for a sensitive tissue diagnosis of BK polyoma-
virus-associated nephropathy in kidney transplant recipients [68].
Moreover, BKV infection of endothelial cells has been reported in
a patient with AIDS and a renal transplant recipient [69,70]. The
kidney uptake reported in the present study was associated with
Figure 9. JC-VLP uptake in spleen. Panels A–I: Mouse tissues were perfusion fixed 7 min after intravenous injection of JC-VLPs. Paraffin sections
of spleen were double immune labeled using a rabbit antiserum against BK-VP1 [53] (reacts also with JC-VP1), and antibodies against F4/80 (A–C),
CD31 (D–F) or CD163 (G–I). Antibodies are listed in Table 1. The VP1 staining pattern (green) showed that the uptake of VLPs was concentrated in the
red pulp marginal zone, mz (A), and here partly co-localized with F4/80 (C, arrow), and CD31 (F, arrows), but not with CD163 (I; arrow indicates VP1,
and arrow head to CD163 staining). The F4/80 (B, C), CD31 (E, F), and CD163 (H, I) staining patterns are all shown in red. Panels J–L: In J–L, tail vein
injection of JC-VLPs was followed by injection of FITC-FSA in the opposite tail vein and tissues perfusion fixed 15 min after the VLP administration.
Both JC-VLP (K; red fluorescence) and FITC-FSA (J; green fluorescence) distributed to the reticuloendothelial network of the spleen red pulp marginal
zone (L; arrows point to overlap of JC-VLP staining and FITC-FSA uptake).
doi:10.1371/journal.pone.0111762.g009
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the endothelial lining of distinct vasa recta segments. Most of the
VLP-positive vessels did not express PV-1/Meca32, suggesting
location of VLPs in the non-fenestrated, or descending part of vasa
recta [61]. The VLP positive endothelial cells also efficiently
endocytosed a functional LSEC marker and scavenger receptor
ligand, FITC-FSA, suggesting high endocytic activity of these cells
compared to other renal endothelia. Whether this uptake will aid
in persistence or clearance of the infectious virus remains to be
revealed.
The brain, which is the main site for JCV pathology (PML) [41],
was not readily identified by the intravenously injected VLPs, as
judged by the extremely low levels of radioactivity accumulating in
this organ. This apparent lack of uptake in brain may be explained
partly by the intact blood-brain and blood-cerebrospinal fluid
barrier of adult mammals. However, the steps in colonization of
the brain by JCV are not well characterized and it is still unclear if
this occurs during primary viremia or during reactivation [41], if it
requires replication competent JCV as opposed to VLPs, or access
via other cell types including B-lymphocytes and/or hematopoietic
progenitor cells [71]. In addition to the usually distinct VP1 amino
acid mutations found [58], virus causing PML bear a rearranged
non-coding control region that increases the replication potential
[72].
We tested the in vivo fate of VLPs of the two of the most
frequently identified JCV mutants, namely JC-VLPL55F and JC-
VLPS269F, both of which have lost their ability to bind alpha(2,6)-
linked sialic acid residues on gangliosides, used by JCV for cellular
entry [41,58]. The rate of blood clearance was rapid, and organ
distribution after 60 min was almost similar for Mad-1 and mutant
JC-VLPs, suggesting that their blood clearance by scavenger cells
did not depend on binding to alpha(2,6)-linked sialic acid
receptors.
The high scavenging capacity of LSECs for most ligands is
mediated by a limited set of high affinity endocytosis receptors
[10]. Together with the mannose receptor, the scavenger receptors
stabilin-1 and stabilin-2 are considered the main endocytic
workhorses of these cells [10,65], and are responsible for the
uptake of a wide range of macromolecules, including oxidized
LDLs, hyaluronan, chondroitin sulphate, procollagen propeptides,
and advanced glycation end products [13,30,65]. Many serum
proteins that are phosphorylated as a consequence of platelet
activation and blood coagulation are also recognized by the LSEC
scavenger receptors [73]. Recent data suggest that the VP1
molecules of BKV contain posttranslational modifications includ-
ing phosphate groups [74]. FSA, a well-known ligand for the
scavenger/stabilin receptors [30,59] was unable to alter the
clearance kinetics of blood-borne VLPs, suggesting that the LSEC
scavenger receptors were not involved in the hepatic uptake of the
particles. However, intracellular degradation of JC-VLPs in liver
was significantly impaired. Together, these data suggest traffic of
FSA and JC-VLP to the same degradation compartments, but via
different receptors. However, we cannot exclude binding to
different sites of the same endocytosis receptor, as non-reciprocal
cross-competition is described for binding of FSA and hyaluronan
to scavenger receptors/stabilin-2 in LSECs [11,13,25]. Mice
deficient in the mannose receptor [46] showed similar clearance
and organ distribution of BK/JC-VLPs as wild-type mice with
normal expression of mannose receptor in LSECs. Although this is
consistent with the fact that polyomavirus VLPs including BKV
and JCV are not glycosylated [74], it should be noted that the
mannose receptor has binding sites for non-glycosylated residues
in addition to acting as a lectin [10,75].
Conclusions
Mouse LSECs were identified as efficient scavengers of BK- and
JC-VLPs. Despite this efficient clearance mechanism, the VLPs
still reached the kidney which is a key organ of BKV and JCV
persistence in humans. Of note, the kidney was targeted by VLPs,
i.e. in the absence of virus replication. Here we identified uptake
predominantly in endothelial cells of the non-fenestrated segments
of vasa recta, which also possessed high endocytic activity towards
the scavenger receptor ligand FITC-FSA, a hitherto unknown
function of these renal endothelial cells. A better understanding of
LSEC-mediated polyomavirus clearance may shed light into the
role of these cells in the development of polyomavirus-associated
diseases. Moreover, this may permit the development of strategies
to harness this process for immunocompromised subjects at risk of
polyoma virus replication.
Supporting Information
Figure S1 Liver distribution of BK- and JC-VLPs –
details of Figure 4B and 4E. The figure shows the green
and red channels, white field (WF) image, and merged image of
immune labeled paraffin sections of liver from mice injected with
BK-VLPs (A–D), or JC-VLPs (E–H). The livers were perfusion
fixed 15 min after intravenous injection, and sections labeled with
rabbit antiserum to BK-VP1 (cross-reacts with JC-VP1), and an
antibody to the mannose receptor (MR; LSEC marker [26]). The
staining patterns of VLPs (A, E; green) and MR (B, F; red) were
similar (overlay in D, H), and localized exclusively to sinusoids (s;
arrowheads), whereas hepatocytes (outlined in C, D, G, H) were
negative. Hn, hepatocyte nucleus.
(TIFF)
Figure S2 Uptake of JC-VLPs in LSECs in vitro – Z-
stack. Freshly isolated LSECs were incubated at 37uC for 1 h
with 10 mg/ml JC-VLPs, fixed, and double immune labeled with
rabbit anti-serum to BK-VP1 (red), and an antibody to an LSEC
marker (the mannose receptor, MR; green). Draq5 was used to
stain the cell nucleus. The panel shows the images of a Z-stack
recorded by confocal laser scanning microscopy. Every image
shows the same cell at different depth (Z axis) with 0.3 mm distance
from the previous optical image, recorded from a given 0 mm (A)
to 1.2 mm depth (E). The intensity of the Draq5 staining increased
gradually from A to D, meaning that the images were taken from a
layer close to the cell plasma membrane in A, towards the center
of the cell in D. Positive VP1 staining (red) can be seen in all
images, indicating cellular uptake of VLPs. The MR is a
constitutively recycling endocytosis receptor in LSECs [14] and
MR staining is strongest towards the periphery of the cell.
(TIFF)
Figure S3 Lectin histochemistry of liver, kidney and
spleen. Panels A–H: Paraffin sections of liver (A, B), kidney
medulla (C, D), kidney cortex (E, F), and spleen (G, H) were
labeled with biotinylated agglutinins: Maackia amurensis II
(MAH; A, C, E, G) that binds to alpha(2,3)-linked sialic acid,
and Sambucus nigra (SNA; B, D, F, H) that binds to alpha(2,6)-
linked sialic acid. Lectin binding to sialic acids was visualized by
Alexa555-streptavidin. Both type of lectins bound to all endothelia
in liver (A, B), and kidney (C–F). In spleen (G–H), the lectin
staining pattern was more diffuse than in the two other organs.
PV, portal vein; CV, central vein; g, glomerulus.
(TIFF)
Figure S4 Effects of the scavenger receptor ligand FSA
on uptake and intracellular degradation of JC-VLP.
Panels A–C: Rate of blood clearance, and subsequent organ
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distribution of 125I-JC-VLP in mice injected with a saturating dose
(0.8 mg/mouse) of the scavenger receptor ligand FSA immediately
prior to the injection of 125I-JC-VLP (dose: 0.5 mg/mouse). Blood
samples were taken at the indicated time points in A, B and
analyzed for 125I-labeled degradation products and intact ligand
[15]. A, B) The graph in A shows decrease of intact ligand in blood
as a function of time, whereas the graph in B shows increase in
degradation products released into the blood with time. Results
are given in cpm per ml blood. Different symbols refer to separate
animals (n = 3). cpm, counts per minute. The slope of the line
drawn in B represents the average release rate of degradation
products in the 10–30 min period after ligand injection where this
release followed approximate first order kinetics. C) Organ
distribution of radioactivity 60 min after the intravenous admin-
istration of 125I-JC-VLP and FSA. *Significantly more radioactiv-
ity (p-value ,0.01) was recovered in liver after 60 min following
competitive inhibition with FSA (Figure S4-C; 44%), than after
injection with 125I-JC-VLP alone (Figure 3B; 30%). U bladder,
urine bladder; GI tract, gastrointestinal tract; FSA, formaldehyde
denatured serum albumin.
(EPS)
Figure S5 Blood clearance and tissue distribution of
125I-JC-VLPs in MR-/- mice. C57BL/6 MR-/- mice (n = 2)
were injected intravenously with approximately 0.5 mg of 125I-JC-
VLP, and blood samples taken at the time points indicated in A
and B and analyzed for 125I-labeled degradation products and
intact ligand [15]. After 60 min, the animals were euthanized,
then perfused free of blood, and radioactivity measured in tissues
and organs. A) Kinetics of decrease of intact 125I-labeled ligand in
blood. B) Increase in 125I-degradation products released into the
blood with time. Results in A and B are given in counts per minute
(cpm) per ml blood. C) Organ distribution of radioactivity 60 min
after injection of ligand. Recovered radioactivity in organs and
tissues at this time point was taken as 100%.
(EPS)
Figure S6 Uptake of blood-borne BK-VLPs in spleen.
The figure shows the distribution of BK-VLPs in spleen 15 min
after intravenous injection. Paraffin sections were stained with
anti-BK-VP1 (Table 1) and Alexa488-goat-anti-rabbit antibody
(green fluorescence). The VLPs were taken up in the reticuloen-
dothelial network in the spleen red pulp marginal zone (mz,
arrowheads). rp, red pulp; wp, white pulp.
(TIF)
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